Wockhardt share news and announcements
NSE: WOCKPHARMABSE: 532300Pharmaceuticals & BiotechnologySmall Cap
Last close ₹1,801.70down ₹53.80 (2.90%)BSE ₹1,801.25
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,855.50.
52-week range of traded prices to 23 Oct 2026
₹1,086.70Low, 23 Mar 2026₹2,422.30High, 1 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹29,276 Cr311th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- 71.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- 5.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 8,79,19043.6% delivered
Wockhardt share news and announcements
1,008 announcements, routine notices left out, newest first. Page 12 of 21.
Sep 2016
16 Sep · News Verification
Exchange has sought clarification from Wockhardt Limited with respect to recent news item captioned "USFDA clears Chikalthana Plant of Wockhardt".In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.
Aug 2016
13 Aug · Regulation 44(3) of SEBI (LODR), Reg., 2015
8 Aug · News Verification
Exchange has sought clarification from Wockhardt Limited with respect to recent news item captioned "Wockhardt gets import alert from US FDA". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.
Jul 2016
21 Jul · News Verification
Exchange has sought clarification from Wockhardt Limited with respect to recent news item captioned "Wockhardt gets establishment inspection RPT for Chikalthana Unit".In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.5 Jul · Legal
Exchange has sought clarification from Wockhardt Limited with respect to announcement dated July 01, 2016, regarding Company has given Corporate Guarantee to secure Term loan of US$ 250 Million facility availed by Wockhardt Bio AG, a subsidiary of the Company. On basis of above the Company is required to clarify following:1. Whether the promoter/ promoter group/ group companies have any interest in this transaction? If yes, nature of interest and details thereof and whether the same is done at arms length ;2. Brief details of such guarantee or indemnity or becoming a surety viz. brief details of agreement entered (if any) including significant terms and conditions, including amount of guarantee;3. Impact of such guarantees or indemnity or surety on listed entity.The response of the Company is awaited.
May 2016
Apr 2016
Feb 2016
Jan 2016
15 Jan · Legal
Exchange has sought clarification from Wockhardt Limited with respect to recent news item captioned "Wockhardt recalls 62,555 bottles of antibiotics in US". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of any information that has not been announced to the Exchanges under regulation 30 of Listing regulations. The response from the Company is awaited.
Dec 2015
Nov 2015
Oct 2015